• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

既往妊娠作为预防黑色素瘤死亡的保护因素。

Previous pregnancy as a protective factor against death from melanoma.

作者信息

Hersey P, Morgan G, Stone D E, McCarthy W H, Milton G W

出版信息

Lancet. 1977 Feb 26;1(8009):451-2. doi: 10.1016/s0140-6736(77)91943-2.

DOI:10.1016/s0140-6736(77)91943-2
PMID:65563
Abstract

Examination of the case-records of women presenting to the Melanoma Unit at Sydney Hospital over the period 1961-71 has shown that women with pregnancies before the development of melanoma had a better survival-rate from melanoma than women without previous pregnancies. The known presence of fetal antigens on melanoma cells and immunisation against fetal antigens during pregnancy suggest an immunological explanation for these results. Exposure to fetal antigens during pregnancy may protect against the dissemination of melanoma cells bearing similar fetal antigens and thus increase the survival-rate. The incidence of melanoma in males and females was approximately equal, which suggests that immune responses to tumour-associated antigens may be more effective in preventing spread of tumours than in preventing their occurrence.

摘要

对1961年至1971年间到悉尼医院黑色素瘤科就诊的女性病例记录进行检查后发现,在黑色素瘤发生前怀孕的女性,其黑色素瘤的生存率高于未怀孕的女性。黑色素瘤细胞上已知存在胎儿抗原,以及孕期针对胎儿抗原进行免疫,这为这些结果提供了一种免疫学解释。孕期接触胎儿抗原可能会防止携带相似胎儿抗原的黑色素瘤细胞扩散,从而提高生存率。男性和女性黑色素瘤的发病率大致相等,这表明对肿瘤相关抗原的免疫反应在预防肿瘤扩散方面可能比对预防肿瘤发生更有效。

相似文献

1
Previous pregnancy as a protective factor against death from melanoma.既往妊娠作为预防黑色素瘤死亡的保护因素。
Lancet. 1977 Feb 26;1(8009):451-2. doi: 10.1016/s0140-6736(77)91943-2.
2
Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients.自发性抗体反应对恶性黑色素瘤患者肿瘤相关抗原的预后意义。
Int J Cancer. 2015 Jan 1;136(1):138-51. doi: 10.1002/ijc.28980. Epub 2014 May 28.
3
Expression of high molecular weight-melanoma associated antigen (HMW-MAA) in primary ALM lesions is associated with a poor prognosis.原发性肢端黑色素瘤(ALM)病灶中高分子量黑色素瘤相关抗原(HMW-MAA)的表达与预后不良相关。
Pigment Cell Res. 1992;Suppl 2:132-5. doi: 10.1111/j.1600-0749.1990.tb00362.x.
4
Previous pregnancy is a favourable prognostic factor in women with localised cutaneous melanoma.既往妊娠是局限性皮肤黑色素瘤妇女的有利预后因素。
Acta Oncol. 2012 May;51(5):662-8. doi: 10.3109/0284186X.2012.673734. Epub 2012 Apr 10.
5
Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1.NY-ESO-1 预先存在体液免疫应答的黑色素瘤患者中伊匹单抗的 II 期试验。
Eur J Cancer. 2018 Feb;90:122-129. doi: 10.1016/j.ejca.2017.12.001. Epub 2018 Jan 5.
6
Improved survival of patients with melanoma with an antibody response to immunization to a polyvalent melanoma vaccine.对多价黑色素瘤疫苗免疫产生抗体反应的黑色素瘤患者生存率提高。
Cancer. 1995 Jan 15;75(2):495-502. doi: 10.1002/1097-0142(19950115)75:2<495::aid-cncr2820750212>3.0.co;2-s.
7
Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.小鼠抗独特型单克隆抗体MK2-23模拟人高分子量黑色素瘤相关抗原:对恶性黑色素瘤患者免疫原性的调节
Clin Cancer Res. 1995 Jul;1(7):705-13.
8
Lack of effect of pregnancy on outcome of melanoma. For The World Health Organisation Melanoma Programme.
Lancet. 1991 Mar 16;337(8742):653-5. doi: 10.1016/0140-6736(91)92462-b.
9
Autonomous histopathological regression of primary tumours associated with specific immune responses to cancer antigens.与针对癌症抗原的特异性免疫反应相关的原发性肿瘤的自主性组织病理学消退。
J Pathol. 2003 Jul;200(3):383-95. doi: 10.1002/path.1369.
10
Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.明确 CD2 在完全切除的 II 期至 III 期皮肤黑色素瘤患者疾病进展和总生存期中的作用。
J Am Acad Dermatol. 2014 Jun;70(6):1036-44. doi: 10.1016/j.jaad.2014.01.914. Epub 2014 Mar 31.

引用本文的文献

1
LNS8801: An Enantiomerically Pure Agonist of the G Protein-Coupled Estrogen Receptor Suitable for Clinical Development.LNS8801:一种对映体纯的G蛋白偶联雌激素受体激动剂,适用于临床开发。
Cancer Res Commun. 2025 Apr 1;5(4):556-568. doi: 10.1158/2767-9764.CRC-24-0632.
2
Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade.G 蛋白偶联雌激素受体信号的激活抑制黑色素瘤并改善对免疫检查点阻断的反应。
Elife. 2018 Jan 16;7:e31770. doi: 10.7554/eLife.31770.
3
Malignant melanoma and pregnancy ten questions.
恶性黑色素瘤与妊娠:十个问题
West J Med. 1996 Feb;164(2):156-61.
4
Malignant melanoma: sex differences in survival after evidence of distant metastasis.恶性黑色素瘤:远处转移证据出现后的生存性别差异。
Br J Cancer. 1980 Jul;42(1):52-7. doi: 10.1038/bjc.1980.202.
5
Uveal melanomas presenting during pregnancy and the investigation of oestrogen receptors in melanomas.孕期出现的葡萄膜黑色素瘤及黑色素瘤中雌激素受体的研究
Br J Ophthalmol. 1982 Nov;66(11):695-704. doi: 10.1136/bjo.66.11.695.
6
Reaction of the leukocytes of melanoma patients and control donors, including pregnant women, with melanoma- and fetus-derived materials.黑色素瘤患者及对照供体(包括孕妇)的白细胞与黑色素瘤及胎儿来源物质的反应。
Cancer Immunol Immunother. 1982;14(2):78-81. doi: 10.1007/BF00200171.
7
Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma Study.生殖因素、口服避孕药与恶性黑色素瘤风险:加拿大西部黑色素瘤研究
Br J Cancer. 1985 Dec;52(6):901-7. doi: 10.1038/bjc.1985.275.
8
Expression by human fetal organs of organ-specific cancer neoantigens as measured by leukocyte adherence inhibition.通过白细胞黏附抑制法检测人胎儿器官中器官特异性癌新抗原的表达。
Cancer Immunol Immunother. 1986;21(2):107-13. doi: 10.1007/BF00199857.
9
Malignant melanoma in pregnancy.妊娠期恶性黑色素瘤
Ulster Med J. 1987 Apr;56(1):72-3.
10
Malignant melanoma: an evolutionary theory to explain its behaviour.恶性黑色素瘤:一种解释其行为的进化理论。
Ann R Coll Surg Engl. 1978 Jan;60(1):14-20.